# The Wine Industry By-Products: Applications for Food Industry and Health Benefits

**Authors:** Raúl Ferrer-Gallego, Paula Silva

PMC · DOI: 10.3390/antiox11102025 · 2022-10-14

## TL;DR

Wine by-products contain healthful compounds that can be used in food to prevent chronic diseases, though more research is needed to improve their effectiveness.

## Contribution

This paper highlights the potential of wine by-products as functional food ingredients with health benefits and identifies areas needing further research.

## Key findings

- Wine by-products are rich in bioactive compounds like polyphenols that offer health benefits.
- Using wine by-products in food can reduce inflammation and improve antioxidant status.
- Wine by-products may help prevent chronic diseases like diabetes and cancer, but their bioavailability needs improvement.

## Abstract

Each year, 20 million tons of wine by-products are generated, corresponding to 30% of the total quantity of vinified grapes. Wine by-products are a source of healthy bioactive molecules, such as polyphenols and other molecules (pigments, fibers, minerals, etc.). The abundance of bioactive compounds assures a promising future for nutritional foodstuff production. Wine by-products can be used to fortify aromatized waters and infusions, bread, pasta, dairy products, alcohol, sugary beverages, and processed foods. These innovative products are part of the Mediterranean diet and are of great interest to both human and environmental health. Pre-clinical studies show that consumption of food produced with wine by-products or with their extracts attenuates the inflammatory state and increases antioxidant status. As such, wine by-products provide protective effects against the underlying pathophysiological hallmarks of some chronic diseases such as atherosclerosis, diabetes, hypertension, obesity, and cancer. However, the poor bioavailability warrants further investigation on how to optimize the efficacy of wine by-products, and more clinical trials are also needed. The scientific evidence has validated the uses of the dietary nature of wine by-products and has helped to promote their use as a functional food to prevent chronic human diseases.

## Linked entities

- **Diseases:** atherosclerosis (MONDO:0005311), diabetes (MONDO:0005015), obesity (MONDO:0011122), cancer (MONDO:0004992)

## Full-text entities

- **Genes:** Tnf (tumor necrosis factor) [NCBI Gene 21926] {aka DIF, TNF-a, TNF-alpha, TNFSF2, TNFalpha, Tnfa}, Npy (neuropeptide Y) [NCBI Gene 109648] {aka 0710005A05Rik}, VCAM1 (vascular cell adhesion molecule 1) [NCBI Gene 7412] {aka CD106, INCAM-100}, Ptgs2 (prostaglandin-endoperoxide synthase 2) [NCBI Gene 19225] {aka COX2, Cox-2, PES-2, PGHS-2, PHS II, PHS-2}, Becn1 (beclin 1, autophagy related) [NCBI Gene 56208] {aka Atg6}, Mir222 (microRNA 222) [NCBI Gene 723828] {aka Mirn222, mir-222, mmu-mir-222}, Nfkb1 (nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105) [NCBI Gene 18033] {aka NF-KB1, NF-kappaB, NF-kappaB1, p105, p50, p50/p105}, Pnlip (pancreatic lipase) [NCBI Gene 69060] {aka 1810007A24Rik, PL, PTL}, INS (insulin) [NCBI Gene 3630] {aka IDDM, IDDM1, IDDM2, ILPR, IRDN, MODY10}, Il10 (interleukin 10) [NCBI Gene 16153] {aka CSIF, If2a, Il-10}, Crp (C-reactive protein, pentraxin-related) [NCBI Gene 12944], Cxcl10 (C-X-C motif chemokine ligand 10) [NCBI Gene 15945] {aka C7, CRG-2, INP10, IP-10, IP10, Ifi10}, Lep (leptin) [NCBI Gene 16846] {aka ob, obese}, GJA1 (gap junction protein alpha 1) [NCBI Gene 2697] {aka AVSD3, CMDR, CX43, EKVP, EKVP3, GJAL}, Il6 (interleukin 6) [NCBI Gene 16193] {aka Il-6}, NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790] {aka CVID12, EBP-1, KBF1, NF-kB, NF-kB1, NF-kappa-B1}, Pcna (proliferating cell nuclear antigen) [NCBI Gene 18538], TXNRD1 (thioredoxin reductase 1) [NCBI Gene 7296] {aka GRIM-12, TR, TR1, TRXR1, TXNR, TXNR1}, Sis (sucrase isomaltase) [NCBI Gene 69983] {aka 2010204N08Rik, SI, Si-s}, CXCL8 (C-X-C motif chemokine ligand 8) [NCBI Gene 3576] {aka GCP-1, GCP1, IL8, LECT, LUCT, LYNAP}, Tnf (tumor necrosis factor) [NCBI Gene 24835] {aka RATTNF, TNF-alpha, Tnfa}, Fgf15 (fibroblast growth factor 15) [NCBI Gene 14170] {aka FGF19, Fgf8a}, ICAM1 (intercellular adhesion molecule 1) [NCBI Gene 3383] {aka BB2, CD54, P3.58}, MMP2 (matrix metallopeptidase 2) [NCBI Gene 4313] {aka CLG4, CLG4A, MMP-2, MMP-II, MONA, TBE-1}, IL1A (interleukin 1 alpha) [NCBI Gene 3552] {aka IL-1 alpha, IL-1A, IL1, IL1-ALPHA, IL1F1}, App (amyloid beta precursor protein) [NCBI Gene 11820] {aka Abeta, Abpp, Adap, Ag, Cvap, E030013M08Rik}, Crp (C-reactive protein) [NCBI Gene 25419] {aka Aa1249, Ab1-341, Ab2-196, Ac1-114, Ac1262, Ac2-069}
- **Diseases:** adenomatous polyposis (MESH:D011125), diabetes (MESH:D003920), weight loss (MESH:D015431), breast cancer (MESH:D001943), NAFLD (MESH:D065626), damage to the liver and brain (MESH:D056486), energy metabolism disorder (MESH:D008659), cancer (MESH:D009369), carcinogenesis (MESH:D063646), impaired fasting glucose (MESH:D007003), liver (MESH:D017093), congestive heart failure (MESH:D006333), cardiotoxicity (MESH:D066126), type II diabetes (MESH:D003924), insulin resistance (MESH:D007333), atherosclerosis (MESH:D050197), adiposity (MESH:D018205), disrupted glucose homeostasis (MESH:D019958), arrhythmias (MESH:D001145), colitis (MESH:D003092), intestinal adenoma (MESH:D007410), adipose tissue inflammation (MESH:D007249), ulcerative colitis (MESH:D003093), Alzheimer's disease (MESH:D000544), familial hypercholesterolemia (MESH:D006938), cardiovascular disease (MESH:D002318), hypertension (MESH:D006973), gastrointestinal cancer (MESH:D005770), myocardial infarction (MESH:D009203), hyperlipidemia (MESH:D006949), overweight (MESH:D050177), ischemia (MESH:D007511), prehypertension (MESH:D058246), myocardial ischemia (MESH:D017202), hepatic steatosis (MESH:D005234), Brain dysfunctions (MESH:D001927), MetS (MESH:D024821), weight gain (MESH:D015430), osteoarthritis (MESH:D010003), chronic diseases (MESH:D002908), ectopic fat deposition (MESH:D004620), colon cancer (MESH:D015179), lesions (MESH:D009059), obese (MESH:D009765)
- **Species:** Flavobacterium (genus) [taxon 237], Lactococcus (lactic streptococci, genus) [taxon 1357], Sus scrofa (pig, species) [taxon 9823], Vitis vinifera (wine grape, species) [taxon 29760], Rattus norvegicus (brown rat, species) [taxon 10116], Homo sapiens (human, species) [taxon 9606], Saccharomyces cerevisiae (baker's yeast, species) [taxon 4932], Bacteria Latreille et al. 1825 (Bacteria stick insect, genus) [taxon 629395], Desulfovibrio (genus) [taxon 872], Allobaculum (genus) [taxon 174708], Labeo rohita (Jayanti rohu, species) [taxon 84645], Mus musculus (house mouse, species) [taxon 10090], Aspergillus niger (species) [taxon 5061], Aspergillus oryzae (species) [taxon 5062], Ascaris suum (pig roundworm, species) [taxon 6253]
- **Mutations:** A1C
- **Cell lines:** C57Bl/6 — Mus musculus (Mouse), Mouse melanoma, Cancer cell line (CVCL_0192), RAW 264.7i — Mus musculus (Mouse), Mouse leukemia, Cancer cell line (CVCL_0493), HMEC-1 — Homo sapiens (Human), Transformed cell line (CVCL_0307), Caco-2 — Homo sapiens (Human), Colon adenocarcinoma, Cancer cell line (CVCL_0025), CCD-18Co — Homo sapiens (Human), Finite cell line (CVCL_2379), MDA-MB-231 — Homo sapiens (Human), Breast adenocarcinoma, Cancer cell line (CVCL_0062), MCF-7 — Homo sapiens (Human), Invasive breast carcinoma of no special type, Cancer cell line (CVCL_0031), C57BL/6J — Mus musculus (Mouse), Transformed cell line (CVCL_C0MW), C57BL/6 — Mus musculus (Mouse), Transformed cell line (CVCL_C0MU), APC10.1 — Homo sapiens (Human), Spontaneously immortalized cell line (CVCL_RQ98)

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC9598427/full.md

---
Source: https://tomesphere.com/paper/PMC9598427